Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Menggang Yu

Showing results (131-140 of 176) with videos related to

Pageof 18
Sort By:
NPJ Genomic Medicine|October 17, 2022
Identification of phenocopies improves prediction of targeted therapy response over DNA mutations aloneHamza Bakhtiar, Kyle T Helzer, Yeonhee Park, et al.
The American Journal of Pathology|February 13, 2018
The Presence of Cyclooxygenase 2, Tumor-Associated Macrophages, and Collagen Alignment as Prognostic Markers for Invasive Breast Carcinoma PatientsKarla Esbona, Yanyao Yi, Sandeep Saha, et al.
Seminars in Arthritis and Rheumatism|April 4, 2021
One Quarter of Medicare Hospitalizations in Patients with Systemic Lupus Erythematosus Readmitted within Thirty DaysChristie M Bartels, Ann Chodara, Yi Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2008
A phase I and pharmacokinetic trial of erlotinib in combination with weekly docetaxel in patients with taxane-naive malignanciesE Gabriela Chiorean, Jennifer M Porter, Anne E Foster, et al.
Leukemia|January 27, 2022
Tcof1 haploinsufficiency promotes early T cell precursor-like leukemia in Nras<sup>Q61R/+</sup> miceZhi Wen, Remington Finn, Xin Gao, et al.
Molecular and Cellular Biology|June 17, 2009
Increased c-Jun expression and reduced GATA2 expression promote aberrant monocytic differentiation induced by activating PTPN11 mutantsZhenyun Yang, Takako Kondo, Cara S Voorhorst, et al.
Head & Neck|March 20, 2023
Dual Axl/MerTK inhibitor INCB081776 creates a proinflammatory tumor immune microenvironment and enhances anti-PDL1 efficacy in head and neck cancerKourtney L Kostecki, Mari Iida, Anne L Wiley, et al.
Investigational New Drugs|February 14, 2009
A phase II study of oral enzastaurin in patients with metastatic breast cancer previously treated with an anthracycline and a taxane containing regimenLida Mina, Ian Krop, Robin T Zon, et al.
Neuro-Oncology|May 24, 2019
Xenograft-based, platform-independent gene signatures to predict response to alkylating chemotherapy, radiation, and combination therapy for glioblastomaShuang G Zhao, Menggang Yu, Daniel E Spratt, et al.
Cancer Chemotherapy and Pharmacology|May 22, 2012
Phase II and gene expression analysis trial of neoadjuvant capecitabine plus irinotecan followed by capecitabine-based chemoradiotherapy for locally advanced rectal cancer: Hoosier Oncology Group GI03-53E Gabriela Chiorean, Sonal Sanghani, Marissa A Schiel, et al.
Pageof 18

Showing results (131-140 of 176) with videos related to

Sort By:
Pageof 18
NPJ Genomic Medicine|October 17, 2022
Identification of phenocopies improves prediction of targeted therapy response over DNA mutations aloneHamza Bakhtiar, Kyle T Helzer, Yeonhee Park, et al.
The American Journal of Pathology|February 13, 2018
The Presence of Cyclooxygenase 2, Tumor-Associated Macrophages, and Collagen Alignment as Prognostic Markers for Invasive Breast Carcinoma PatientsKarla Esbona, Yanyao Yi, Sandeep Saha, et al.
Seminars in Arthritis and Rheumatism|April 4, 2021
One Quarter of Medicare Hospitalizations in Patients with Systemic Lupus Erythematosus Readmitted within Thirty DaysChristie M Bartels, Ann Chodara, Yi Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2008
A phase I and pharmacokinetic trial of erlotinib in combination with weekly docetaxel in patients with taxane-naive malignanciesE Gabriela Chiorean, Jennifer M Porter, Anne E Foster, et al.
Leukemia|January 27, 2022
Tcof1 haploinsufficiency promotes early T cell precursor-like leukemia in Nras<sup>Q61R/+</sup> miceZhi Wen, Remington Finn, Xin Gao, et al.
Molecular and Cellular Biology|June 17, 2009
Increased c-Jun expression and reduced GATA2 expression promote aberrant monocytic differentiation induced by activating PTPN11 mutantsZhenyun Yang, Takako Kondo, Cara S Voorhorst, et al.
Head & Neck|March 20, 2023
Dual Axl/MerTK inhibitor INCB081776 creates a proinflammatory tumor immune microenvironment and enhances anti-PDL1 efficacy in head and neck cancerKourtney L Kostecki, Mari Iida, Anne L Wiley, et al.
Investigational New Drugs|February 14, 2009
A phase II study of oral enzastaurin in patients with metastatic breast cancer previously treated with an anthracycline and a taxane containing regimenLida Mina, Ian Krop, Robin T Zon, et al.
Neuro-Oncology|May 24, 2019
Xenograft-based, platform-independent gene signatures to predict response to alkylating chemotherapy, radiation, and combination therapy for glioblastomaShuang G Zhao, Menggang Yu, Daniel E Spratt, et al.
Cancer Chemotherapy and Pharmacology|May 22, 2012
Phase II and gene expression analysis trial of neoadjuvant capecitabine plus irinotecan followed by capecitabine-based chemoradiotherapy for locally advanced rectal cancer: Hoosier Oncology Group GI03-53E Gabriela Chiorean, Sonal Sanghani, Marissa A Schiel, et al.
Pageof 18